Obama rarely highlights the fact that reform would provide protections against price differentials that often result in discrimination based on age and gender.
The U.S. Preventive Services Task Force, an independent panel of nongovernment clinicians who provide evidence-based practice guidelines, recommends against screening men over age 75 for prostate cancer.